Signaling Pathways - NAT10 - KDM - Insulin and Insulin-like Receptors - Neuraminidases (NA)
清除全部
- B4930 TC-E 5002Target: KDMSummary: 选择性组蛋白去甲基化酶KDM2/7亚家族抑制剂
- B4887 RemodelinTarget: NAT10Summary: NAT10抑制剂
- B1803 Oseltamivir phosphate1 Citation中文名: 磷酸奥司他韦Target: Neuraminidases (NA)Summary: 有效的选择性神经氨酸酶抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3944 X-NeuNAcTarget: Neuraminidases (NA)Summary: 神经氨酸酶活性显色试验的底物
- A3689 Oseltamivir acid1 Citation中文名: 奥斯他伟酸,奥司他韦羧酸,奥司他韦酸,奥塞米韦酸Target: Neuraminidases (NA)Summary: 流感神经氨酸酶抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A3348 Daminozide中文名: 丁酰肼Target: KDM|PHFSummary: KDM2A抑制剂